Cargando…
The treatment of acute promyelocytic leukemia in 2023: Paradigm, advances, and future directions
The transformation of acute promyelocytic leukemia (APL) from an often fatal to highly curable cancer with long-term survival exceeding 90% is one of the greatest and most inspiring successes in oncology. A deeper understanding of the pathogenesis of APL heralded the introduction of highly effective...
Autores principales: | Iyer, Sunil Girish, Elias, Laila, Stanchina, Michele, Watts, Justin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889825/ https://www.ncbi.nlm.nih.gov/pubmed/36741714 http://dx.doi.org/10.3389/fonc.2022.1062524 |
Ejemplares similares
-
Profile of Glasdegib for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML): Evidence to Date
por: Iyer, Sunil Girish, et al.
Publicado: (2022) -
Hypertriglyceridemia in Newly Diagnosed Acute Promyelocytic Leukemia
por: Sun, Jianai, et al.
Publicado: (2020) -
SERS-Based Assessment of MRD in Acute Promyelocytic Leukemia?
por: Turcas, Cristina, et al.
Publicado: (2020) -
Evolving Chemotherapy Free Regimens for Acute Promyelocytic Leukemia
por: Kulkarni, Uday, et al.
Publicado: (2021) -
The History of the Chemo-Free Model in the Treatment of Acute Promyelocytic Leukemia
por: Zhu, Hong-Hu
Publicado: (2020)